Boy, 9, dying of cancer has new hope after miracle drug newly-approved in the US

A newly-approved cancer drug called Vitrakvi (larotrectinib) offers hope to patients, including Ashton Leeds, a 9-year-old boy with stage 4 thyroid cancer, by targeting specific genetic mutations